The DOI matches its Crossref record; 722 of the 722 references it cites were found in a registry or an index.
Current and Potential Drugs for Treatment of Obesity
Abstract
I. Introduction II. Criteria for Evaluating the Efficacy of Antiobesity Treatment III. Physiological and Pharmacological Mechanisms to Reduce Food Intake A. Peripherally acting agents B. Centrally acting agents IV. Drugs That Alter Metabolism A. Preabsorptive agents B. Postabsorptive modifiers of nutrient metabolism V. Drugs That Increase Energy Expenditure A. Thyroid hormone B. Adrenergic thermogenic drugs VI. Conclusion
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–400 of 722
Behavior Therapy and Pharmacotherapy for Obesity
Craighead, L. W. (1981) · Archives of General Psychiatry · doi:10.1001/archpsyc.1981.01780320043003 · Cited by 166
Regulation of cholecystokinin secretion by intraluminal releasing factors
Liddle, R. A. (1995) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1995.269.3.g319 · Cited by 165
Holtzman, S. G. (1979) · Life Sciences · doi:10.1016/0024-3205(79)90222-4 · Cited by 165
Lukaski, H., Bolonchuk, W., Siders, W., & Milne, D. (1996) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/63.6.954 · Cited by 164
The MONA LISA hypothesis in the time of leptin.
Bray, G. A., & York, D. A. (1998) · PubMed · Cited by 164
Self-citationMultiple lipolysis defects in the insulin resistance (metabolic) syndrome.
Reynisdottir, S., Ellerfeldt, K., Wahrenberg, H., Lithell, H., & Arner, P. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117271 · Cited by 163
Effects of long-term therapy with naltrexone on body weight in obesity
Atkinson, R. L., Berke, L. K., Drake, C. R., Bibbs, M. L., Williams, F. L., & Kaiser, D. L. (1985) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1985.197 · Cited by 163
Role of the Sympathetic Nervous System in Blood Pressure Maintenance in Obesity
SOWERS, J. R., WHITFIELD, L. A., CATANIA, R. A., STERN, N., TUCK, M. L., DORNFELD, L., & MAXWELL, M. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-54-6-1181 · Cited by 162
Alger, S., Schwalberg, M., Bigaouette, J., Michalek, A., & Howard, L. (1991) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/53.4.865 · Cited by 162
Bromocriptine (Ergoset) Reduces Body Weight and Improves Glucose Tolerance in Obese Subjects
Cincotta, A. H., & MEIER, A. H. (1996) · Diabetes Care · doi:10.2337/diacare.19.6.667 · Cited by 162
Acetylation alters the feeding response to MSH and beta-endorphin
Tsujii, S., & Bray, G. A. (1989) · Brain Research Bulletin · doi:10.1016/0361-9230(89)90142-1 · Cited by 161
Self-citationLong-term weight control study: Conclusions
Weintraub, M. (1992) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1992.76 · Cited by 161
Seidell, J. C., Björntorp, P. A., Sjöström, L.-G., Sannerstedt, R., Krotkiewski, M., & Kvist, H. (1989) · PubMed · Cited by 158
Original Articles Sibutramine Reduces Food Intake in Non‐Dieting Women with Obesity
Rolls, B. J., Shide, D. J., Thorwart, M. L., & Ulbrecht, J. S. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00308.x · Cited by 158
Lucas, J. J., Yamamoto, A., Scearce-Levie, K. A., Saudou, F., & Hen, R. (1998) · Journal of Neuroscience · doi:10.1523/jneurosci.18-14-05537.1998 · Cited by 157
Effects of calcitonin gene-related peptide on food intake
Krahn, D. D., Gosnell, B. A., Levine, A. S., & Morley, J. E. (1984) · Peptides · doi:10.1016/0196-9781(84)90107-4 · Cited by 157
Sibutramine--a review of clinical efficacy.
Lean, M. E. J. (1997) · PubMed · Cited by 157
Lecklin, A., Etu-Seppälä, P., Stark, H., & Tuomisto, L. M. (1998) · Brain Research · doi:10.1016/s0006-8993(98)00186-3 · Cited by 156
Fluoxetine: a randomized clinical trial in the treatment of obesity.
GOLDSTEIN, D. J., Rampey, A. H., Enas, G. G., Potvin, J. H., Fludzinski, L. A., & Levine, L. R. (1994) · PubMed · Cited by 155
Treatment of the seriously obese patient
Wadden, T. A., & Itallie, T. B. V. (1992) · Medical Entomology and Zoology · Cited by 155
Sibutramine: a review of the pharmacology of a novel anti-obesity agent.
Stock, M. (1997) · PubMed · Cited by 155
Strategies and Potential Molecular Targets for Obesity Treatment
Campfield, L. A., Smith, F. J., & Burn, P. (1998) · Science · doi:10.1126/science.280.5368.1383 · Cited by 153
Davis, J. D., Wirtshafter, D., Asin, K. E., & Brief, D. J. (1981) · Science · doi:10.1126/science.7193909 · Cited by 152
Obesity: a time bomb to be defused
Bray, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(98)22029-0 · Cited by 152
Self-citationLipase inhibition: a novel concept in the treatment of obesity.
Drent, M. L., & van der Veen, E. A. (1993) · PubMed · Cited by 151
Efficacy and tolerability of orlistat in the treatment of obesity: a 6-month dose-ranging study
Gaal, L. F. V., Broom, J. I., Enzi, G., & Toplak, H. (1998) · European Journal of Clinical Pharmacology · doi:10.1007/s002280050433 · Cited by 149
Obesity, Diabetes and Functions for Proopiomelanocortin-derived Peptides
Mountjoy, K. G., & Wong, J. (1997) · Molecular and Cellular Endocrinology · doi:10.1016/s0303-7207(96)04017-8 · Cited by 149
The Actions of Exogenous Dehydroepiandrosterone in Experimental Animals and Humans
Švec, F., & Porter, J. R. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-218-44285 · Cited by 149
The Treatment of Mild Hypertension Study
(1991) · Archives of Internal Medicine · doi:10.1001/archinte.1991.00400070161023 · Cited by 147
Growth Hormone Administration Conserves Lean Body Mass during Dietary Restriction in Obese Subjects*
Clemmons, D. R., Snyder, D. K., Williams, R. W., & Underwood, L. E. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-878 · Cited by 145
The lateral hypothalamus: a primary site mediating excitatory amino acid-elicited eating
Stanley, B. G., Willett, V. L., Donias, H. W., Ha, L. H., & Spears, L. C. (1993) · Brain Research · doi:10.1016/0006-8993(93)90640-9 · Cited by 145
Bray, G. A. (1975) · Cited by 145
Self-citationEffect of free fatty acid on the rat lateral hypothalamic neurons
Oomura, Y., Nakamura, T., Sugimori, M., & Yamada, Y. (1975) · Physiology & Behavior · doi:10.1016/0031-9384(75)90015-3 · Cited by 144
Goodall, E. M., Cowen, P. J., Franklin, M., & Silverstone, T. (1993) · Psychopharmacology · doi:10.1007/bf02244895 · Cited by 144
Astrup, A. V., Toubro, S., Cannon, S., Hein, P., & Madsen, J. (1991) · Metabolism · doi:10.1016/0026-0495(91)90117-f · Cited by 143
Invernizzi, R. W., Berettera, C., Garattini, S. K., & SAMANIN, R. (1986) · European Journal of Pharmacology · doi:10.1016/0014-2999(86)90633-3 · Cited by 143
Okada, S., York, D. A., Bray, G. A., & Erlanson‐Albertsson, C. (1991) · Physiology & Behavior · doi:10.1016/0031-9384(91)90349-s · Cited by 142
Self-citationRichelsen, B., Pedersen, S. B., Børglum, J. D., Møller–Pedersen, T., Jørgensen, J. O. L., & Jørgensen, J. O. L. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.266.2.e211 · Cited by 142
Presse, F., Sorokovsky, I., Max, J., Nicolaı̈dis, S., & Nahon, J. (1996) · Neuroscience · doi:10.1016/0306-4522(95)00481-5 · Cited by 140
Lustig, R. H., Rose, S. R., Burghen, G. A., Velasquez-Mieyer, P., Broome, D. C., Smith, K., Li, H., Hudson, M. M., Heideman, R. L., & Kun, L. E. (1999) · The Journal of Pediatrics · doi:10.1016/s0022-3476(99)70017-x · Cited by 138
Bray, G. A. (2018) · Cited by 136
Self-citationTHE MECHANISM OF AMPHETAMINE-INDUCED LOSS OF WEIGHT
Harris, S. C. (1947) · JAMA · doi:10.1001/jama.1947.02880340022005 · Cited by 136
Thompson, J. L., Butterfield, G. E., Gylfadottir, U., Yesavage, J. A., Marcus, R., Hintz, R. L., Pearman, A., & Hoffman, A. R. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.5.4826 · Cited by 135
Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect
GEARY, N., & SMITH, G. (1983) · Physiology & Behavior · doi:10.1016/0031-9384(83)90207-x · Cited by 134 · cited 1×
“Glucagon is a 29-amino acid peptide that reduces food intake after peripheral administration (173, 250) (Table 5).”
BackgroundIndividual, but not simultaneous, glucagon and cholecystokinin infusions inhibit feeding in men
Geary, N., Kissileff, H. R., Pi-Sunyer, X., & Hinton, V. J. (1992) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1992.262.6.r975 · Cited by 134
Sequence Variants in the Sulfonylurea Receptor (SUR) Gene Are Associated With NIDDM in Caucasians
Inoue, H., Ferrer, J. P., Welling, C. M., Elbein, S. C., Hoffman, M. D., Mayorga, R. A., Warren-Perry, M., Zhang, Y., Millns, H., Turner, R. C., et al. (1996) · Diabetes · doi:10.2337/diab.45.6.825 · Cited by 133
Prospects for beta 3-adrenoceptor agonists in the treatment of obesity and diabetes.
Arch, J. R. S., & Wilson, S. (1996) · PubMed · Cited by 132
Intracerebroventricular infusions of 3-OHB and insulin in a rat model of dietary obesity
Arase, K., Fisler, J. S., Shargill, N. S., York, D. A., & Bray, G. A. (1988) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1988.255.6.r974 · Cited by 132
Self-citationCassard, A., Bouillaud, F., Mattéi, M., Hentz, E., Raimbault, S., Thomas, M., & Ricquier, D. (1990) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240430306 · Cited by 132
Satiating Effect of Cholecystokinina
Smith, G. P., & Gibbs, J. (1994) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1994.tb44071.x · Cited by 131
Reduced insulin secretion: an independent predictor of body weight gain
Schwartz, M. W., Boyko, E. J., Kahn, S. E., Ravussin, É., & Bogardus, C. (1995) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.80.5.7745002 · Cited by 131
Testosterone and Regional Fat Distribution
Mårin, P. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00233.x · Cited by 129
Failure of dehydroepiandrosterone to influence energy and protein metabolism in humans.
WELLE, S., JOZEFOWICZ, R., & STATT, M. (1990) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-71-5-1259 · Cited by 126
NALOXONE DECREASES FOOD INTAKE IN OBESE HUMANS
Atkinson, R. L. (1982) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-55-1-196 · Cited by 125
Fluoxetine-induced weight loss in overweight non-depressed humans.
Ferguson, J. M., & Feighner, J. P. (1987) · PubMed · Cited by 124
Interactions of lipoprotein lipase with the active‐site inhibitor tetrahydrolipstatin (Orlistat)R
Lõokene, A., Škottová, N., & Olivecrona, G. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18878.x · Cited by 124
(1998) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780195105155.001.0001 · Cited by 123
Serotonin, Eating Behavior, and Fat Intake
Blundell, J. E., Lawton, C. L., & Halford, J. C. G. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00214.x · Cited by 122
Effect of (−)‐hydroxycitrate upon the accumulation of lipid in the rat: II. Appetite
Sullivan, A. C., Triscari, J. M., Hamilton, J. G. C., & Miller, O. N. (1974) · Lipids · doi:10.1007/bf02532137 · Cited by 122
Davis, B., Blaufox, M. D., Oberman, A., Wassertheil-Smoller, S., Zimbaldi, N., Cutler, J. A., Kirchner, K., & Langford, H. G. (1993) · Archives of Internal Medicine · doi:10.1001/archinte.153.15.1773 · Cited by 121
Molecular and genetic aspects of obesity
Bray, G. A., & Ryan, D. H. (1996) · Louisiana State University Press eBooks · Cited by 120
Self-citationSimons, J., Schols, A. M. W. J., Hoefnagels, J. M. J., Westerterp, K. R., ten Velde, G. P. M., & Wouters, E. F. �. (1998) · Cancer · doi:10.1002/(sici)1097-0142(19980201)82:3<553::aid-cncr18>3.0.co;2-0 · Cited by 120
Clancy, S. P., Clarkson, P. M., DeCheke, M. E., Nosaka, K., Freedson, P. S., Cunningham, J. J., & Valentine, B. (1994) · International Journal of Sport Nutrition · doi:10.1123/ijsn.4.2.142 · Cited by 118
A one-year trial to assess the value of orlistat in the management of obesity.
James, W. P. T., Avenell, A., Broom, J. I., & Whitehead, J. (1997) · PubMed · Cited by 118
Feeding induced by opiates injected into the paraventricular hypothalamus.
Mclean, S., & Hoebel, B. (1983) · Peptides · doi:10.1016/0196-9781(83)90134-1 · Cited by 118
Treatment of seasonal depression with d-fenfluramine.
O’Rourke, D. M., Wurtman, J. J., Wurtman, R. J., Chebli, R., & Gleason, R. E. (1989) · PubMed · Cited by 118
Capsaicin abolishes lipoprivic but not glucoprivic feeding in rats
Ritter, S., & Taylor, J. (1989) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1989.256.6.r1232 · Cited by 118
Fluoxetine's effect on weight loss in obese subjects
Darga, L. L., Carroll-Michals, L., Botsford, S., & Lucas, C. P. (1991) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/54.2.321 · Cited by 116
Pharmacokinetics of Oral Decongestants
Kanfer, I., Dowse, R., & Vuma, V. (1993) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1993.tb02780.x · Cited by 115
Brain Peptides and Obesity: Pharmacologic Treatment
LEIBOWITZ, S. F. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00230.x · Cited by 115
The role of thyroid hormones and insulin in the regulation of energy metabolism
Danforth, E. (1983) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/38.6.1006 · Cited by 114
LEIBOWITZ, S. F., & Rossakis, C. (1979) · Brain Research · doi:10.1016/0006-8993(79)90899-0 · Cited by 114
Control of energy intake by energy metabolism
Friedman, M. I. (1995) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/62.5.1096s · Cited by 114
Dulloo, A. G., Seydoux, J., & Girardier, L. (1992) · Metabolism · doi:10.1016/0026-0495(92)90015-3 · Cited by 113
Cholecystokinin octapeptide decreases intake of solid food in man
Stacher, G., Steinringer, H., Schmierer, G., Schneider, C., & Winklehner, S. (1982) · Peptides · doi:10.1016/0196-9781(82)90041-9 · Cited by 113
Multiple Serotonin Receptors: Opportunities for New Treatments for Obesity?
Dourish, C. T. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00212.x · Cited by 113
Baranski, J. V., & Pigeau, R. (1997) · Journal of Sleep Research · doi:10.1111/j.1365-2869.1997.00032.x · Cited by 113
Serotoninergic modulation of the pattern of eating and the profile of hunger-satiety in humans.
Schwartz, R. S., Jaeger, L. F., Silberstein, S., & Veith, R. C. (1987) · PubMed · Cited by 112
Egawa, M., Yoshimatsu, H., & Bray, G. A. (1990) · Neuroscience · doi:10.1016/0306-4522(90)90181-3 · Cited by 112
Self-citationHimms‐Hagen, J. (1995) · Experimental Biology and Medicine · doi:10.3181/00379727-208-43847a · Cited by 112
Maheux, P., Ducros, F., Bourque, J., Garon, J., & Chiasson, J. L. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800372 · Cited by 112
Studies on food intake of genetically obese rats
Bray, G. A., & York, D. A. (1972) · American Journal of Physiology-Legacy Content · doi:10.1152/ajplegacy.1972.223.1.176 · Cited by 112
Self-citationNeurochemical Mechanism of Action of Anorectic Drugs
SAMANIN, R., & Garattini, S. K. (1993) · Pharmacology & Toxicology · doi:10.1111/j.1600-0773.1993.tb01537.x · Cited by 110
McTavish, D., & Heel, R. C. (1992) · Drugs · doi:10.2165/00003495-199243050-00007 · Cited by 109
Mooney, K. W., & Cromwell, G. L. (1995) · Journal of Animal Science · doi:10.2527/1995.73113351x · Cited by 108
Pancreatic procolipase propeptide, enterostatin, specifically inhibits fat intake
Erlanson‐Albertsson, C., Mei, J., Okada, S., York, D. A., & Bray, G. A. (1991) · Physiology & Behavior · doi:10.1016/0031-9384(91)90350-w · Cited by 108
Self-citationThe Pharmacology of α‐Adrenergic Decongestants
Johnson, D. A., & Hricik, J. G. (1993) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1993.tb02779.x · Cited by 107
LEIBOWITZ, S. F., Weiss, G. F., Yee, F., & Tretter, J. B. (1985) · Brain Research Bulletin · doi:10.1016/0361-9230(85)90105-4 · Cited by 107
Hani, E., Clément, K., Velho, G., Vionnet, N., Hager, J., Philippi, A., Dina, C., Inoue, H., Permutt, M., Basdevant, A., et al. (1997) · Diabetes · doi:10.2337/diab.46.4.688 · Cited by 107
LEIBOWITZ, S. F., Weiss, G. F., & Shor‐Posner, G. (1988) · PubMed · Cited by 106
Modulation of food intake by peripherally administered amylin
Morley, J. E., Flood, J. F., Horowitz, M., Morley, P. M. K., & Walter, M. J. (1994) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1994.267.1.r178 · Cited by 106
Further Cases of Valvular Heart Disease Associated with Fenfluramine–Phentermine
Graham, D. J., & Green, L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708283370911 · Cited by 105
Dulloo, A. G. (1993) · PubMed · Cited by 104
Heal, D. J., Cheetham, S. C., Prow, M. R., Martin, K. F., & Buckett, W. R. (1998) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702067 · Cited by 104
Enterostatin‐A Peptide Regulating Fat Intake
Erlanson‐Albertsson, C., & Yorkf, D. (1997) · Obesity Research · doi:10.1002/j.1550-8528.1997.tb00565.x · Cited by 104
Cangiano, C., Ceci, F., Cascino, A., Ben, M. D., Laviano, A., Muscaritoli, M., Antonucci, F., & Fanelli, F. R. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.5.863 · Cited by 102
Sibutramine: A Novel New Agent for Obesity Treatment
Ryan, D. H., Kaiser, P., & Bray, G. A. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00227.x · Cited by 102
Self-citationMcCann, U. D. (1997) · JAMA · doi:10.1001/jama.278.8.666 · Cited by 102
Hillebrand, I., Boehme, K., Frank, G., Fink, H., & Berchtold, P. (1979) · Research in Experimental Medicine · doi:10.1007/bf01851236 · Cited by 101
High-dose naltrexone therapy and dietary counseling for obesity
Mitchell, J. E., Morley, J. E., Levine, A. S., Hatsukami, D., Gannon, M. C., & Pfohl, D. (1987) · Biological Psychiatry · doi:10.1016/0006-3223(87)90127-2 · Cited by 100
Snyder, D. K., Clemmons, D. R., & Underwood, L. E. (1989) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-69-4-745 · Cited by 100
Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus
Kreymann, B., Ghatei, M. A., Burnet, P. W. J., Williams, G., Kanse, S. M., Diani, A. R., & Bloom, S. R. (1989) · Brain Research · doi:10.1016/0006-8993(89)90628-8 · Cited by 99
Connacher, A. A., Jung, R. T., & Mitchell, P. (1988) · BMJ · doi:10.1136/bmj.296.6631.1217 · Cited by 99
Efficacy and tolerability of sibutramine in obese patients: a dose-ranging study
Hanotin, C., Thomas, F., Jones, S. W., Leutenegger, É., & Drouin, P. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800540 · Cited by 99
BRL 35135, a potent and selective atypical β-adrenoceptor agonist
Cawthorne, M., Sennitt, M. V., Arch, J., & Smith, S. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.252s · Cited by 98
Selective hepatic vagotomy eliminates the hypophagic effect of different metabolites
Langhans, W., Egli, G., & Scharrer, E. (1985) · Journal of the Autonomic Nervous System · doi:10.1016/0165-1838(85)90014-1 · Cited by 98
Mechanisms of vasopressin's anorectic effect
Langhans, W., Delprete, E., & Scharrer, E. (1991) · Physiology & Behavior · doi:10.1016/0031-9384(91)90251-i · Cited by 98
Effects of chromium picolinate on beginning weight training students
Hasten, D. L., Rome, E. P., Franks, B. D., & Hegsted, M. (1992) · International Journal of Sport Nutrition · doi:10.1123/ijsn.2.4.343 · Cited by 97 · cited 2×
“The only significant difference was a greater increase in body weight in the females supplemented with chromium picolinate (888).”
BackgroundNEWHOUSE, P. A. (1989) · Neuropsychopharmacology · doi:10.1016/0893-133x(89)90018-3 · Cited by 97
Effects of olestra, a noncaloric fat substitute, on daily energy and fat intakes in lean men
Rolls, B., Pirraglia, P., Jones, M., & Peters, J. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/56.1.84 · Cited by 97
Moscucci, M. M., Byrne, L., WEINTRAUB, M. I., & Cox, C. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.26 · Cited by 97
A controlled trial of naltrexone in obese humans.
Malcolm, R. J., O'Neil, P. M., Sexauer, J. D., Fe, R., Currey, H. S., & Counts, C. (1985) · PubMed · Cited by 97
Okada, K., Ishii, S., Minami, S., Sugihara, H., Shibasaki, T., & Wakabayashi, I. (1996) · Endocrinology · doi:10.1210/endo.137.11.8895390 · Cited by 96
The origins and consequences of obesity
Treasure, J. L. (1997) · Behaviour Research and Therapy · doi:10.1016/s0005-7967(97)85351-x · Cited by 95
Neurotensin: Effects of hypothalamic and intravenous injections on eating and drinking in rats
Stanley, B. G., Hoebel, B. G., & LEIBOWITZ, S. F. (1983) · Peptides · doi:10.1016/0196-9781(83)90054-2 · Cited by 95
Treatment of the Seriously Obese Patient
Albright, A. L., & Stern, J. S. (1993) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/58.2.245 · Cited by 95
Effects of corticotropin releasing hormone on appetitive behaviors
Glowa, J. R., Barrett, J. E., Russell, J., & Gold, P. W. (1992) · Peptides · doi:10.1016/0196-9781(92)90097-m · Cited by 94
LEIBOWITZ, S. F., & Brown, L. L. (1980) · Brain Research · doi:10.1016/0006-8993(80)91038-0 · Cited by 94
Fluoxetine in the Treatment of Obese Type 2 Diabetic Patients
O’Kane, M. P. M., Wiles, P. G., & Wales, J. K. (1994) · Diabetic Medicine · doi:10.1111/j.1464-5491.1994.tb00238.x · Cited by 94
Hepatic versus cerebral origin of stimulus for feeding induced by 2-deoxy-{d}-glucose in rats.
Stricker, E. M., & Rowland, N. E. (1978) · Journal of Comparative and Physiological Psychology · doi:10.1037/h0077454 · Cited by 94
Pharmacotherapy for Obesity — Do the Benefits Outweigh the Risks?
Manson, J. E., & Faich, G. A. (1996) · New England Journal of Medicine · doi:10.1056/nejm199608293350910 · Cited by 93
Tonstad, S., Pometta, D., Erkelens, D. W., Ose, L., Moccetti, T., Schouten, J. A., Golay, A., Reitsma, J. B., Bufalo, A. D., Pasotti, E., et al. (1994) · European Journal of Clinical Pharmacology · doi:10.1007/bf00191901 · Cited by 93
Abdominal vagotomy does not block the satiety effect of bombesin in the rat
Smith, G. P., Jerome, C., & Gibbs, J. (1981) · Peptides · doi:10.1016/s0196-9781(81)80096-4 · Cited by 93
Davis, R., & Faulds, D. M. (1996) · Drugs · doi:10.2165/00003495-199652050-00007 · Cited by 93
The origins and consequences of obesity
Chadwick, D., & Cardew, G. (1996) · Medical Entomology and Zoology · Cited by 92
Metabolic Profiles of Minimally Absorbed Orlistat in Obese/Overweight Volunteers
Zhi, J., Melia, A. T., Funk, C., Viger, A., Gérard Hopfgartner, D., Lausecker, B., Wang, K., Fulton, J. S., Gabriel, L., & Mulligan, T. E. (1996) · The Journal of Clinical Pharmacology · doi:10.1177/009127009603601104 · Cited by 92
Höppener, J. W. M., Verbeek, J. S., de Koning, E. J. P., Oosterwijk, C., van Hulst, K. L., Visser-Vernooy, H. J., Hofhuis, F. M., van Gaalen, S., Berends, M. J. H., Hackeng, W. H. L., et al. (1993) · Diabetologia · doi:10.1007/bf00400803 · Cited by 92
Pancreatic glucagon signals postprandial satiety
Geary, N. (1990) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80042-9 · Cited by 92
A Placebo-Controlled Trial of d-Fenfluramine in Bulimia Nervosa
Fahy, T. A., Eisler, I., & Russell, G. F. M. (1993) · The British Journal of Psychiatry · doi:10.1192/bjp.162.5.597 · Cited by 92
Use of a serotonin re-uptake inhibitor, fluoxetine, in the treatment of obesity.
Levine, L. R., Rosenblatt, S., & Bosomworth, J. C. (1987) · PubMed · Cited by 92
Enhanced thermogenic responsiveness during chronic ephedrine treatment in man
Astrup, A. V., Lundsgaard, C. C., Madsen, J., & CHRISTENSEN, N. J. (1985) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/42.1.83 · Cited by 91
Kotz, C. M., Grace, M. K., Briggs, J., Levine, A., & Billington, C. J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci118017 · Cited by 90
Contribution of beta 3-adrenoceptor activation to ephedrine-induced thermogenesis in humans.
Liu, Y., Toubro, S., Astrup, A. V., & Stock, M. J. (1995) · PubMed · Cited by 89
Effects of Sibutramine on Resting Metabolic Rate and Weight Loss in Overweight Women
SEAGLE, H. M., Bessesen, D. H., & Hill, J. O. (1998) · Obesity Research · doi:10.1002/j.1550-8528.1998.tb00324.x · Cited by 89
Increased food intake after type A but not type B cholecystokinin receptor blockade
Corwin, R. L., Gibbs, J., & Smith, G. P. (1991) · Physiology & Behavior · doi:10.1016/0031-9384(91)90529-w · Cited by 88
Blundell, J. E., & Leshem, M. (1975) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1975.tb09374.x · Cited by 88
Stunkard, A. J. (1980) · The Lancet · doi:10.1016/s0140-6736(80)92272-2 · Cited by 87
Long-term Weight Control Study VI
WEINTRAUB, M. I., Sundaresan, P. R., & Cox, C. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.74 · Cited by 87
ATP‐sensitive K+ channels: Pharmacologic properties, regulation, and therapeutic potential
Gopalakrishnan, M., Janis, R. A., & Triggle, D. J. (1993) · Drug Development Research · doi:10.1002/ddr.430280202 · Cited by 87
Effect of intravenous human gastrin-releasing peptide on food intake in humans
Gutzwiller, J., Drewe, J., Hildebrand, P., Rossi, L., Lauper, J. Z., & Beglinger, C. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90006-x · Cited by 86
Treatment of refractory obesity with fenfluramine.
Munro, J., Seaton, D., & Duncan, L. J. P. (1966) · BMJ · doi:10.1136/bmj.2.5514.624 · Cited by 86
Tolerance to anorectic drugs: pharmacological or artifactual.
Levitsky, D., Strupp, B., & Lupoli, J. (1981) · Pharmacology, Biochemistry and Behavior · doi:10.1016/0091-3057(81)90128-3 · Cited by 85
One year comparative trial of metformin and glipizide in type 2 diabetes mellitus.
Campbell, I. W., Menzies, D. G., Chalmers, J., McBain, A. M., & Brown, I. R. F. (1994) · PubMed · Cited by 85
Ephedrine, caffeine and aspirin: safety and efficacy for treatment of human obesity.
Daly, P. A., Krieger, D., Dulloo, A. G., Young, J. B., & Landsberg, L. (1993) · PubMed · Cited by 84
McGuirk, J., & Silverstone, T. (1990) · PubMed · Cited by 84
Lack of effect of dehydroepiandrosterone in obese men.
Usiskin, K., Butterworth, S., Clore, J. N., Arad, Y., Ginsberg, H. N., Blackard, W. G., & Nestler, J. (1990) · PubMed · Cited by 84
Effects of corticotropin releasing factor on genetically obese (fatty) rats
Arase, K., Shargill, N. S., & Bray, G. A. (1989) · Physiology & Behavior · doi:10.1016/0031-9384(89)90074-7 · Cited by 84
Self-citationMyerson, A., Loman, J., Rinkel, M., & Lesses, M. F. (1938) · American Heart Journal · doi:10.1016/s0002-8703(38)90612-x · Cited by 83
Human Autonomic Pharmacology: XVI. Benzedrine Sulfate as an Aid in the Treatment of Obesity
Lesses, M. F., & Myerson, A. (1938) · New England Journal of Medicine · doi:10.1056/nejm193801202180307 · Cited by 83
First Clinical Studies with Orlistat: A Short Review
Drent, M. L., & van der Veen, E. A. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00236.x · Cited by 82
Enterostatin suppresses food intake following injection into the third ventricle of rats
Shargill, N. S., Tsujii, S., Bray, G. A., & Erlanson‐Albertsson, C. (1991) · Brain Research · doi:10.1016/0006-8993(91)90895-3 · Cited by 81
Self-citationObesity: Basic considerations and clinical approaches
Bray, G. A. (1989) · Disease-a-Month · doi:10.1016/0011-5029(89)90007-2 · Cited by 81
Self-citationGlucose modulation of alterations in serum iodothyronine concentrations induced by fasting
Burman, K. D., Dimond, R. C., Harvey, G. S., O’Brian, J. T., Georges, L. P., Bruton, J., WRIGHT, F. D., & Wartofsky, L. (1979) · Metabolism · doi:10.1016/0026-0495(79)90098-2 · Cited by 81
Hamamura, M., Leng, G., Emson, P. C., & Kiyama, H. (1991) · The Journal of Physiology · doi:10.1113/jphysiol.1991.sp018865 · Cited by 81
Davidson, M. B., & CHOPRA, I. J. (1979) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-48-4-577 · Cited by 81
Metabolic response to human growth hormone during prolonged starvation
Felig, P., Marliss, E. B., & Cahill, G. F. (1971) · Journal of Clinical Investigation · doi:10.1172/jci106508 · Cited by 81
Preoptic area injection of corticotropin-releasing hormone stimulates sympathetic activity
Egawa, M., Yoshimatsu, H., & Bray, G. A. (1990) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1990.259.4.r799 · Cited by 81
Self-citationThe effect of ephedrine/caffeine mixture on energy expenditure and body composition in obese women
Astrup, A. V., Buemann, B., Christensen, N. J., Toubro, S., Thorbek, G., Victor, O. J., & QUAADE, F. (1992) · Metabolism · doi:10.1016/0026-0495(92)90304-s · Cited by 80
Pieber, T. R., Roitelman, J., Lee, Y. J., Luskey, K. L., & Stein, D. T. (1994) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1994.267.1.e156 · Cited by 80
Lovejoy, J. C., Bray, G. A., Greeson, C. S., Klemperer, M., Morris, J., Partington, C. R., & Tulley, R. T. (1995) · PubMed · Cited by 79
Self-citationAnorexia following the systemic injection of amylin
Chance, W. T., Balasubramaniam, A., Stallion, A., & Fischer, J. E. (1993) · Brain Research · doi:10.1016/0006-8993(93)91505-m · Cited by 79
Chronic infusion of norepinephrine into the ventromedial hypothalamus induces obesity in rats
Shimazu, T., Noma, M., & Saito, M. (1986) · Brain Research · doi:10.1016/0006-8993(86)90530-5 · Cited by 79
Differential effects of amphetamine and fenfluramine on dietary self-selection in rats
Orthen-Gambill, N., & Kanarek, R. B. (1982) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(82)90164-2 · Cited by 78
Glucagon-like peptide-1 and satiety
van Dijk, G., Thiele, T. E., Seeley, R. J., Woods, S. C., & Bernstein, I. L. (1997) · Nature · doi:10.1038/385214a0 · Cited by 78
Brummer, R. J., LÖNNS, L., Kvist, H., Grangård, U., Bengtsson, B. Å., & Sjöström, L. (1993) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.1993.tb00762.x · Cited by 78
Clinical studies with fluoxetine in obesity
Wise, S. (1992) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/55.1.181s · Cited by 77
Lee, M. C., Schiffman, S. S., & Pappas, T. N. (1994) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(94)90045-0 · Cited by 77
Exercise and the regulation of energy intake
Scheurink, A. J. W., Ammar, A. A., Benthem, B., van Dijk, G., & Södersten, P. (1999) · International Journal of Obesity · doi:10.1038/sj.ijo.0800876 · Cited by 77
Fujimoto, K., Machidori, H., Iwakiri, R., et al. (1993) · Brain Research · doi:10.1016/0006-8993(93)91463-3 · Cited by 76
A comparison of fenfluramine and amphetamine in man
Griffith, J. D., Nutt, J. G., & Jasinski, D. R. (1975) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1975185part1563 · Cited by 76
Serotonin and Appetite Regulation: Implications for the Pharmacological Treatment of Obesity
Blundell, J. E., & Halford, J. C. G. (1998) · CNS Drugs · doi:10.2165/00023210-199809060-00005 · Cited by 75
The Amphetamines: Toxicity and Addiction.
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-81-3-425_2 · Cited by 75
Effects of chromium picolinate on body composition.
Trent, L. K., & Thieding-Cancel, D. (1995) · PubMed · Cited by 74
Dopamine Receptor Subtype Agonists and Feeding Behavior
Terry, P., Gilbert, D. B., & Cooper, S. J. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00221.x · Cited by 74
Williams, D. P., Boyden, T. W., Pamenter, R. W., Lohman, T. G., & Going, S. B. (1993) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.77.1.8325963 · Cited by 74
Weight reduction in osteoarthritis using phentermine.
Willims, R. A., & Foulsham, B. M. (1981) · PubMed · Cited by 74
Reciprocal relation between the sympathetic nervous system and food intake
Bray, G. A. (1991) · Brain Research Bulletin · doi:10.1016/0361-9230(91)90152-a · Cited by 73
Self-citationRole of the liver in the metabolic control of eating: What we know—and what we do not know
Langhans, W. (1996) · Neuroscience & Biobehavioral Reviews · doi:10.1016/0149-7634(95)00045-g · Cited by 73
Jørgensen, J. O. L., Pedersen, S. B., Børglum, J. D., Møller, N., Schmitz, O., Christiansen, J. S., & Richelsen, B. (1994) · Metabolism · doi:10.1016/0026-0495(94)90269-0 · Cited by 73
Ryan, D. H., Bray, G. A., Helmcke, F., Sander, G. E., Vólaufová, J., Greenway, F. L., Subramaniam, P., & Glancy, D. L. (1999) · Obesity Research · doi:10.1002/j.1550-8528.1999.tb00414.x · Cited by 73
Self-citationAxon-Sparing Brain Lesioning Technique: The Use of Monosodium-L-Glutamate and Other Amino Acids
Simson, E. L., Gold, R. M., Standish, L. J., & Pellett, P. L. (1977) · Science · doi:10.1126/science.910144 · Cited by 72
Dexfenfluramine neurotoxicity in brains of non-human primates
Ricaurte, G. A., Martello, M. B., Martello, A., Wilson, M. A., Molliver, M. E., & Katz, J. L. (1991) · The Lancet · doi:10.1016/0140-6736(91)92301-h · Cited by 72
Antiobesity effect of diazoxide in obese zucker rats
Alemzadeh, R., Jacobs, W., & Pitukcheewanont, P. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90287-5 · Cited by 72
Kyrkouli, S. E., Stanley, B. G., Hutchinson, R. K., Seirafi, R. D., & LEIBOWITZ, S. F. (1990) · Brain Research · doi:10.1016/0006-8993(90)91541-n · Cited by 72
Elevated insulin and satiety in obese and normal-weight rats
Vanderweele, D. A., Haraczkiewicz, E., & Itallie, T. B. V. (1982) · Appetite · doi:10.1016/s0195-6663(82)80003-2 · Cited by 72
Long-term weight control study II (weeks 34 to 104)
WEINTRAUB, M. I., Sundaresan, P. R., Schuster, B., Ginsberg, G., Madan, M., Balder, A., Stein, E., & Byrne, L. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.70 · Cited by 72
Wolever, T., Chiasson, J.-L., Josse, R., Hunt, J., Palmason, C., Rodger, N., Ross, S., Ryan, E., & Tan, M. (1997) · International Journal of Obesity · doi:10.1038/sj.ijo.0800468 · Cited by 71
Sjöström, L., Rissanen, A., Andersen, T., Boldrin, M. N., Golay, A., Koppeschaar, H. P. F., & Krempf, M. (2000) · PubMed · Cited by 71
Comparison of Tolbutamide and Metformin in Elderly Diabetic Patients
Josephkutty, S., & Potter, J. (1990) · Diabetic Medicine · doi:10.1111/j.1464-5491.1990.tb01433.x · Cited by 71
Kalivas, P. W., & Taylor, S. (1985) · Brain Research · doi:10.1016/0006-8993(85)90949-7 · Cited by 71
MEIER, A. H., Cincotta, A. H., & Lovell, W. C. (1992) · Cellular and Molecular Life Sciences · doi:10.1007/bf01930467 · Cited by 70
Nagase, H., Bray, G. A., & York, D. A. (1996) · Brain Research · doi:10.1016/0006-8993(95)01292-3 · Cited by 69
Self-citationStructural requirements for the biological activity of enterostatin
Lin, L., Okada, S., York, D. A., & Bray, G. A. (1994) · Peptides · doi:10.1016/0196-9781(94)90041-8 · Cited by 69
Self-citationMolecular Biology of Serotonin Receptors
Baez, M., Kursar, J. D., Helton, L. A., Wainscott, D. B., & Nelson, D. L. G. (1995) · Obesity Research · doi:10.1002/j.1550-8528.1995.tb00211.x · Cited by 69
Mecanismos de hipertensión en obesidad
de Fez, C. M. L., Gaztelu, M. T., Rubio, T., & Castaño, A. (2004) · Anales del Sistema Sanitario de Navarra · doi:10.4321/s1137-66272004000300006 · Cited by 69
(1974) · Annals of Internal Medicine · doi:10.7326/0003-4819-80-4-565_2 · Cited by 67
Cangiano, C., Laviano, A., Ben, M. D., Preziosa, I., Angelico, F., Cascino, A., & Fanelli, F. R. (1998) · International Journal of Obesity · doi:10.1038/sj.ijo.0800642 · Cited by 66
Debons, A. F., Siclari, E., Das, K. C., & FUHR, B. (1982) · Endocrinology · doi:10.1210/endo-110-6-2024 · Cited by 66
Naltrexone and human eating behavior: A dose-ranging inpatient trial in moderately obese men
Maggio, C. A., Presta, E., Bracco, E. F., et al. (1985) · Brain Research Bulletin · doi:10.1016/0361-9230(85)90115-7 · Cited by 66
Anabolic effects of growth hormone in obese diet-restricted subjects are dose dependent
Snyder, D., Underwood, L., & Clemmons, D. (1990) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/52.3.431 · Cited by 66
Cited by
Barlow, S. E., & and the Expert Committee (2007) · Pediatrics · doi:10.1542/peds.2007-2329c · Cited by 4,497
Lau, D. C. W., Douketis, J. D., Morrison, K. M., Hramiak, I. M., Sharma, A. M., Ur, E., & Panel, F. M. O. T. O. C. C. P. G. E. (2007) · Canadian Medical Association Journal · doi:10.1503/cmaj.061409 · Cited by 1,154
Recommendations for Treatment of Child and Adolescent Overweight and Obesity
Spear, B. A., Barlow, S. E., Ervin, C., Ludwig, D. S., Saelens, B. E., Schetzina, K. E., & Taveras, E. M. (2007) · Pediatrics · doi:10.1542/peds.2007-2329f · Cited by 856
Meta-Analysis: Pharmacologic Treatment of Obesity
Li, Z., Maglione, M., Tu, W., Mojica, W., Arterburn, D., Shugarman, L. R., Hilton, L., Suttorp, M., Solomon, V., Shekelle, P. G., et al. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-7-200504050-00012 · Cited by 774
Appropriate Intervention Strategies for Weight Loss and Prevention of Weight Regain for Adults
JAKICIC (CHAIR), J. M., CLARK, K., COLEMAN, E., DONNELLY, J. E., FOREYT, J., MELANSON, E., VOLEK, J., & VOLPE, S. L. (2001) · Medicine & Science in Sports & Exercise · doi:10.1097/00005768-200112000-00026 · Cited by 752
Metadata
- Authors
- Bray, G. A., & Greenway, F. L.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 1999-12-01
- Volume
- 20
- Issue
- 6
- Pages
- 805-875
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2007700773
- Cited by
- 331
- References
- 722
- FWCI
- 10.50
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.